MAY
4
Back by Popular Demand - KRAS G12C Mutation: An Emerging Biomarker for NSCLC Sponsored by Amgen
5
Combating COVID-19 – Monoclonal Antibody Therapies to Optimize Patient Care: HHS/ASPR COVID-19 Therapeutics program
6
Myasthenia Gravis: How antibody testing helps you in the management of your patient
Give Us Your Feedback
Presentation: Beyond the hype: Where genomics is having an impact on outcomes
Presentation: Key Considerations for Health Plans for an Effective Approach to Genetic Testing
Publication: Arginine to ornithine ratio as a diagnostic marker in patients with positive newborn screening for hyperargininemia
Publication: Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing
Publication: Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.
Publication: Effectiveness of Practices to Support Appropriate Laboratory Test Utilization: A Laboratory Medicine Best Practices Systematic Review and Meta-Analysis.
Publication: Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.